Lupus

Active Research Protocols

  1. 02-AR-0131 – Collection Of Blood Components Using Apheresis from Patients with Rheumatic Diseases and Healthy Volunteers
  2. 02-AR-0272 – A Phase I, Open-Labeled, Dose-Ascending Clinical Trial of Immunotherapy of MRA, A Humanized Anti-IL 6 Receptor Monoclonal Antibody, In Patients with Systemic Lupus Erythematosus
  3. 03-DK-0071 – Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy
  4. 03-E-0099 – Pathogenic Studies In Families With Twins Or Siblings Discordant For Systemic Rheumatic Disorders
  5. 04-C-0095 – A Pilot Study of Intensified Lymphodepletion Followed by Autologous Hematopoietic Stem Cell Transplantation in Patients with Severe Systemic Lupus Erythematosus
  6. 08-AR-0008 – Insulin Resistance and Atherosclerosis in a Sample of Women with Systemic Lupus Erythematosus
  7. 10-EI-0140 – Genotype-Phenotype Study of Patients with Plaquenil¨-Induced Retinal Toxicity, with Evaluation of the ABCA4 Gene
  8. 13-AR-0005 – A Phase 1b, Randomized, Double-Blind, Placebo Controlled Study with an Open Label Extension to Evaluate the Safety and Tolerability of Omalizumab, A Humanized IgG1 Monoclonal Antibody in Patients with Lupus (STOP LUPUS)
  9. 92-DK-0156 – Studies of Immunologically-Mediated Kidney Diseases
  10. 94-AR-0066 – Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE)
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014